3.51
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
18.32%
3.343
|
4.093 | 5.418 | 4.307 | 5.814 |
| Operating Income/Loss |
0.30%
-8.272
|
-8.247 | -13.85 | -8.655 | -10.33 |
| Net Income/Loss |
3.47%
-7.821
|
-7.559 | -12.98 | -7.749 | -9.385 |
| Basic Average Shares |
0.09%
3.2087
|
3.2059 | 0.0023 | 3.1787 | 3.1689 |
| Diluted Average Shares |
0.09%
3.2087
|
3.2059 | 0.0023 | 3.1787 | 3.1689 |
| Basic Earnings Per Share |
3.39%
-2.44
|
-2.36 | -4.09 | -2.44 | -2.96 |
| Diluted Earnings Per Share |
3.39%
-2.44
|
-2.36 | -4.09 | -2.44 | -2.96 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):